Japanese authorities have arrested three individuals for illegally selling diabetes medication through social media, highlighting growing concerns about the unauthorized use of prescription drugs for weight loss among the general public. The Osaka Prefectural Police sent papers to prosecutors against three suspects accused of selling diabetes treatment medications without proper licenses, according to NHK. The case has drawn attention to a troubling trend in Japan: the increasing use of diabetes medications for diet purposes by people without the condition. The Ministry of Health, Labour and Welfare has issued warnings about health risks associated with using these prescription drugs for weight loss without medical supervision. The suspects allegedly advertised and sold the medications through social networking sites, targeting individuals seeking quick weight-loss solutions. This method of distribution bypasses Japan's strict pharmaceutical regulations, which require proper medical consultation and prescription for such medications. The unauthorized sale of prescription drugs violates Japan's Pharmaceutical Affairs Law, which mandates that certain medications can only be dispensed by licensed pharmacies with valid prescriptions. The medication in question, commonly known by the brand name Mounjaro (tirzepatide), has gained popularity on social media platforms as a weight-loss solution, despite being approved specifically for diabetes treatment. According to Yahoo Japan, discussions about Mounjaro have spread rapidly across social networks, often downplaying or ignoring potential side effects. Health experts warn that using diabetes medications without proper medical supervision can lead to serious health complications. These drugs work by affecting blood sugar levels and metabolism, which can cause dangerous side effects in people without diabetes. Potential adverse reactions include severe nausea, vomiting, diarrhea, dehydration, and in extreme cases, pancreatitis or kidney problems. For non-diabetic users, the risk of hypoglycemia (dangerously low blood sugar) is particularly concerning. The trend reflects a broader global phenomenon where diabetes and pre-diabetes medications are being repurposed for cosmetic weight loss. However, medical professionals emphasize that these drugs are designed for patients with specific metabolic conditions and should only be used under close medical supervision with regular monitoring. For foreign residents in Japan, this case serves as an important reminder about medication safety and legal compliance. Japan maintains strict regulations on pharmaceutical sales and usage, and purchasing prescription medications without proper authorization can result in legal consequences for both sellers and buyers. Additionally, using medications obtained through unofficial channels poses significant health risks, as the drugs may be counterfeit, improperly stored, or administered without appropriate medical guidance. Expats seeking weight management solutions should consult with licensed healthcare providers who can recommend safe, appropriate treatments. Many international clinics in major Japanese cities offer services in English and other languages, making it easier for foreign residents to access legitimate medical care. The Ministry of Health, Labour and Welfare continues to monitor the situation and has urged the public to avoid purchasing medications through social media or other unauthorized channels. Authorities are also working to increase awareness about the dangers of using prescription drugs for off-label purposes without medical supervision. Anyone experiencing health issues or seeking medical treatment in Japan should visit registered medical facilities and obtain medications only through licensed pharmacies with valid prescriptions. This ensures both legal compliance and personal safety, protecting individuals from potentially dangerous health consequences associated with unsupervised medication use. As this case demonstrates, the convenience of social media purchases cannot outweigh the serious health and legal risks involved in obtaining prescription medications through illegal channels.